scholarly journals Predicting Lymph Node Involvement in Borderline Ovarian Tumors with a Quantitative Model and Nomogram: A Retrospective Cohort Study

2021 ◽  
Vol Volume 13 ◽  
pp. 1529-1539
Author(s):  
Menglei Zhang ◽  
Fangyue Zhou ◽  
Yuan He ◽  
Xiang Tao ◽  
Keqin Hua ◽  
...  
Keyword(s):  
Cohort Study ◽  
Lymph Node ◽  
Retrospective Cohort Study ◽  
Retrospective Cohort ◽  
Lymph Node Involvement ◽  
Quantitative Model ◽  
Ovarian Tumors ◽  
Borderline Ovarian Tumors ◽  
Node Involvement

scholarly journals Regional lymph node infiltration and thick lesions are associated with poor prognosis in high-risk resected melanomas: A retrospective cohort study

2021 ◽  
Vol 61 ◽  
pp. 132-138
Author(s):  
Sumadi Lukman Anwar ◽  
Roby Cahyono ◽  
Heru Yudanto Budiman ◽  
Widya Surya Avanti ◽  
Wirsma Arif Harahap ◽  
...  
Keyword(s):  
Cohort Study ◽  
Lymph Node ◽  
High Risk ◽  
Retrospective Cohort Study ◽  
Retrospective Cohort ◽  
Poor Prognosis ◽  
Regional Lymph Node

scholarly journals Clinicopathologic characteristics, laboratory parameters, treatment protocols, and outcomes of pancreatic cancer: a retrospective cohort study of 1433 patients in China

PeerJ ◽  
2018 ◽  
Vol 6 ◽  
pp. e4893 ◽  
Author(s):  
Shuisheng Zhang ◽  
Xiaozhun Huang ◽  
Yuan Tian ◽  
Saderbieke Aimaiti ◽  
Jianwei Zhang ◽  
...  
Keyword(s):  
Pancreatic Cancer ◽  
Cohort Study ◽  
Prognostic Factors ◽  
Lymph Node ◽  
Distant Metastasis ◽  
Retrospective Cohort Study ◽  
Retrospective Cohort ◽  
Clinicopathologic Characteristics ◽  
Treatment Protocols ◽  
Laboratory Parameters

Objectives The prognosis of people with pancreatic cancer is extremely unfavorable. However, the prognostic factors remain largely undefined. We aimed to perform comprehensive analyses of clinicopathologic characteristics, laboratory parameters, and treatment protocols for exploring their role as prognostic factors of pancreatic cancer. Methods Patients diagnosed with pancreatic cancer and hospitalized at the China National Cancer Center between April 2006 and May 2016 were enrolled in this retrospective cohort study. Clinicopathologic characteristics, laboratory parameters, and treatment protocols were compared among patients at different stages of the disease. The association between these factors and overall survival (OS) was analyzed using the Kaplan–Meier method and Cox proportional hazards model. Results The present study included 1,433 consecutive patients with pancreatic cancer. Median OS was 10.6 months (95% confidence interval [CI] 9.8–11.3 months), with 1-, 3-, and 5-year survival rates of 43.7%, 14.8%, and 8.8%, respectively. Cox multivariate analysis findings identified the following factors as independent predictors of OS: gender (female vs male, hazard ratio 0.72, 95% CI [0.54–0.95]); elevated total bilirubin (TBil; 1.82, 1.34–2.47); elevated carbohydrate antigen 19-9 (CA19-9; 1.72, 1.17–2.54); tumor being located in pancreatic body and tail (1.52, 1.10–2.10); advanced T stage (T3-4 vs T1-2, 1.62, 1.15–2.27); lymph node metastasis (1.57, 1.20–2.07); distant metastasis (1.59, 1.12–2.27); the presence of surgical resection (0.53, 0.34–0.81); and the presence of systemic chemotherapy (0.62, 0.45–0.82). Conclusions Being male, elevated TBil and carcinoembryonic antigen, tumor being located in pancreatic body and tail, advanced T stage, lymph node and distant metastasis, the absence of surgical resection, and the absence of systematic chemotherapy were associated with worse OS in patients with pancreatic cancer.

Sign in / Sign up

Export Citation Format

Share Document